LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor
Clinical trial NCT04973527 · TERMINATED
Trial details
- NCT number
- NCT04973527
- Sponsor
- Beijing Boren Hospital
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2022-07-11
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.